Compound Libraries Cancer Cell Differentiation Compound Library

Cancer Cell Differentiation Compound Library

Catalog No. L2140
  Library Compound List   Excel SDF

Cell differentiation is a multifaceted process that depends on complex regulatory networks that involve transcriptional, post-transcriptional and epigenetic regulation of gene expression. In cancer, this describes how much or how little tumor tissue looks like the normal tissue it came from. Well-differentiated cancer cells look more like normal cells and tend to grow and spread more slowly than poorly differentiated or undifferentiated cancer cells. Differentiation is used in tumor grading systems, which are different for each type of cancer.

In addition to apoptosis resistance and cell proliferation capacities, the undifferentiated state also characterizes most cancer cells, especially leukemia cells. The induction of cancer cell differentiation is considered an alternative approach to elicit cell death and proliferation arrest. Differentiation therapy has mainly been developed to treat acute myeloid leukemia, notably with all-trans retinoic acid (ATRA). Numerous molecules from diverse natural or synthetic origins are effective alone or in association with ATRA in both in vitro and in vivo experiments. During the last two decades, pharmaceuticals and natural compounds with various chemical structures, including alkaloids, flavonoids and polyphenols, were identified as potential differentiating agents of hematopoietic pathways and osteogenesis.

TargetMol collects 413 reported compounds inducing cancer cell differentiation as Cancer Cell Differentiation Compound Library, which can be used for high throughput and high content screening for drug discovery.

Pack Size Price/USD
100 μL * 10 mM (in DMSO) 4900.00
250 μL * 10 mM (in DMSO) 8800.00
1 mg 8800.00
If the above compound libraries do not match your needs,
please contact our compound library specialist for a customized compound library at [email protected]
Request Library
Get quote

Product Description

  • A unique collection of 413 cancer cell differentiation inducing compounds for high throughput and high content screening;
  • Detailed compound information with structure, target, activity, IC50 value, and biological activity description;
  • Structurally diverse, medicinally active, and cell permeable;
  • NMR and HPLC validated to ensure high purity and quality;

Library Customization

Targetmol Compound Libraries can be highly customized! Learn More

Packaging And Storage

  • Powder or pre-dissolved DMSO solutions in 96/384 well plate with optional 2D barcode
  • Shipped with blue ice
Request Library Compound List (L2140)

Library Composition

PI3K (69)
HDAC (43)
mTOR (38)
GSK-3 (24)
Akt (21)
DNA-PK (20)
ATM/ATR (16)
Wnt/beta-catenin (16)
S6 Kinase (12)
AMPK (9)
CDK (8)
Gamma-secretase (7)
PDK (7)
PKA (4)
PDE (4)
Autophagy (4)
Carbonic Anhydrase (3)
Chk (3)
Dehydrogenase (3)
EGFR (3)
Epigenetic Reader Domain (3)
ROCK (3)
Src (3)
TGF-beta/Smad (3)
TNF (2)
NF-κB (2)
PKC (2)
PPAR (2)
P450 (2)
HER (2)
DNA/RNA Synthesis (2)
FGFR (2)
FLT (2)
Adenosine Receptor (2)
Adrenergic Receptor (2)
Vitamin (2)
Wnk (1)
ALK (1)
Arginase (1)
ATPase (1)
Aurora Kinase (1)
cholecystokinin (1)
c-Kit (1)
c-Myc (1)
Casein Kinase (1)
Bcr-Abl (1)
GABA Receptor (1)
AChR (1)
GluR (1)
Hck (1)
ERK (1)
Estrogen/progestogen Receptor (1)
Fatty Acid Synthase (1)
DHFR (1)
c-Fms (1)
Histamine Receptor (1)
HIV Protease (1)
HSV (1)
IGF-1R (1)
IL Receptor (1)
JNK (1)
lysosomal autophagy (1)
MAPK (1)
MEK (1)
MELK (1)
MMP (1)
Hedgehog/Smoothened (1)
Retinoid Receptor (1)
Phospholipase (1)
PLK (1)
Potassium Channel (1)
SGK (1)
Topoisomerase (1)
Tyrosine Kinases (1)
TLR (1)